Neurology ReviewsPoor Olfaction May Predict Rapid Cognitive Decline in Parkinson’s DiseaseMay 31, 2016Movement DisordersParkinson's Disease
Neurology ReviewsEarly Signs May Precede Parkinson’s Disease Diagnosis by Six YearsMay 27, 2016Movement DisordersParkinson's Disease
Neurology ReviewsHigh Blood Pressure Predicts Motor Decline in Parkinson’s DiseaseMay 26, 2016Movement DisordersParkinson's Disease
Neurology ReviewsBiopsy of Submandibular Gland May Aid in Early Diagnosis of Lewy Body DisordersMay 26, 2016Movement DisordersAlzheimer's & CognitionParkinson's Disease
Clinical Neurology NewsStrong gender difference for stroke in diabetes patients with restless legs syndromeMay 8, 2016StrokeMovement Disorders
Clinical Neurology NewsStrong gender difference for stroke in diabetes patients with restless legs syndromeMay 8, 2016StrokeMovement Disorders
Clinical Neurology NewsFDA approves first drug to treat hallucinations in Parkinson’s psychosisMay 2, 2016Movement Disorders
Neurology ReviewsRosacea Is a Risk Factor for Parkinson’s DiseaseApril 29, 2016Movement DisordersParkinson's Disease
Neurology ReviewsRemotely Collected Data From Patients With Parkinson’s Disease Now Publicly AvailableApril 29, 2016Movement DisordersParkinson's Disease
Neurology ReviewsChromosomal Deletion May Increase the Risk of Parkinson’s DiseaseApril 29, 2016Movement DisordersParkinson's Disease
Neurology ReviewsValbenazine Reduces Tardive Dyskinesia SeverityApril 25, 2016Movement DisordersParkinson's Disease
Clinical Neurology NewsExtended-release amantadine may improve levodopa dyskinesia controlApril 21, 2016Movement Disorders
Neurology ReviewsAAN Updates Guidelines on Use of Botulinum Toxin for Four DisordersApril 19, 2016Headache & MigraineMovement DisordersParkinson's Disease
Clinical Neurology NewsAAN updates botulinum toxin guidelines for most established usesApril 19, 2016StrokeMultiple SclerosisMovement DisordersNeuromuscular DisordersPain
